Eli Lilly and Co (LLY)

LLY (NYSE:Drugs) EQUITY
$78.90
pos +0.00
+0.00%
Today's Range: 76.02 - 79.55 | LLY Avg Daily Volume: 4,150,000
Last Update: 05/29/15 - 4:02 PM EDT
Volume: 0
YTD Performance: 14.36%
Open: $0.00
Previous Close: $76.41
52 Week Range: $58.50 - $79.55
Oustanding Shares: 1,109,741,140
Market Cap: 84,795,320,507
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 5 5
Moderate Buy 1 1 1 1
Hold 5 6 9 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.95 2.04 2.23 2.23
Latest Dividend: 0.50
Latest Dividend Yield: 2.62%
Dividend Ex-Date: 05/14/15
Price Earnings Ratio: 37.27
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
37.27 37.40 26.87
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
12.44% 32.67% 91.04%
GROWTH 12 Mo 3 Yr CAGR
Revenue -15.10 -0.19 -0.07
Net Income -49.00 -0.45 -0.18
EPS -48.50 -0.43 -0.17
Earnings for LLY:
EBITDA 4.71B
Revenue 19.62B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $0.74 $0.77 $3.15 $3.51
Number of Analysts 7 7 10 9
High Estimate $0.80 $0.85 $3.21 $3.91
Low Estimate $0.68 $0.68 $3.09 $3.21
Prior Year $0.68 $0.66 $2.78 $3.15
Growth Rate (Year over Year) 9.24% 16.88% 13.42% 11.18%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

updateLLY Investor Mtg.

May 4, 2015 | 6:35 AM EDT

LLY - Eli Lilly and Co Annual Shareholders Meeting - 11AM

By

Jim Cramer

 | Mar 31, 2015 | 11:33 AM EDT

Combined Heinz-Kraft heads a long second-quarter list.

By

Chris Laudani

 | Mar 24, 2015 | 9:00 AM EDT

Its Alzheimer's treatment impressed, but dosing questions remain.

By

Gary Morrow

 | Mar 23, 2015 | 2:48 PM EDT

Lilly's stock blossoms, while Amgen is headed for a pullback.

By

Jim Cramer

 | Mar 23, 2015 | 6:00 AM EDT

Here are healthcare stocks of all shares and sizes with strong charts.

updateLeerink Healthcare Conf.

Feb 11, 2015 | 6:41 AM EST

Leerink Global Healthcare Conference (Day 1 of 2) - 02/11/15 - 02/12/15 New York, NY

By

Gary Dvorchak

 | Feb 9, 2015 | 10:00 AM EST

Should you be tempted by the energy names?

bullishEli Lilly upgraded at Goldman

Jan 15, 2015 | 7:08 AM EST

LLY was upgraded to Neutral, Goldman Sachs said. $70 price target. Company is improving margins and can deliver double-digit annual earnings growth in the next few years. 

bearishEli Lilly downgraded at BofA/Merrill

Jan 9, 2015 | 7:08 AM EST

LLY was downgraded to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $74 price target. 

bearishEli Lilly downgraded at Deutsche

Jan 8, 2015 | 8:01 AM EST

LLY was downgraded from Buy to Hold, Deutsche Bank said. $75 price target. Valuation call, as the stock gained 35% in 2014. 

Ford continues to underwhelm. The stock has been in a steady drift lower since its Ma...
This past week, 10-year YIELD broke and sustained below key support at 2.18% - 2.15%, and ...
Eli Lilly is trading at new 52 week highs today. The drug manufacturer is up over 3.25...
On May 15 and 18 I mentioned here about adding some Jun 29 calls, our price was 1.75. The...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.